| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 140 | 5.602 | 15.105 | 29.829 | 38.764 | 42.287 | 47.644 |
| Total Income - EUR | - | - | - | 140 | 5.602 | 15.105 | 29.829 | 38.764 | 42.686 | 48.241 |
| Total Expenses - EUR | - | - | - | 388 | 704 | 1.327 | 10.530 | 13.747 | 20.068 | 21.171 |
| Gross Profit/Loss - EUR | - | - | - | -248 | 4.898 | 13.778 | 19.299 | 25.017 | 22.618 | 27.070 |
| Net Profit/Loss - EUR | - | - | - | -252 | 4.730 | 13.355 | 18.690 | 24.209 | 22.220 | 25.651 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Acapella Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 23.020 | 15.986 | 8.854 | 1.761 |
| Current Assets | - | - | - | 72 | 4.622 | 13.568 | 19.468 | 19.690 | 18.643 | 51.280 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 49 | 52 | 0 |
| Receivables | - | - | - | 0 | 1.112 | 0 | 0 | 207 | 320 | 26.370 |
| Cash | - | - | - | 72 | 3.511 | 13.568 | 19.468 | 19.435 | 18.271 | 24.910 |
| Shareholders Funds | - | - | - | -209 | 4.525 | 13.405 | 26.339 | 24.258 | 20.901 | 25.700 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 281 | 97 | 163 | 16.148 | 11.418 | 6.597 | 27.341 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Acapella Med S.r.l.